CAS: 105047-45-8; Fmoc-Lys-Oh

该化合物是一种受保护的氨酸衍生物,广泛用于固相聚丙酸合成(SPPS),Fmoc(9-氟氧基碳基)组是一个防雷小组,确保在温和基本条件下有选择性地取消保护,同时保持侧链功能.氨类赖氨基赖氨基水仍不受保护或可进一步修改,提供多功能的浸泡设计.该化合物因其纯度高,稳定性和与标准SPPS协议的兼容性而备受重视.其可靠性能有利于复杂的peptids合成,尤其是那些需要正方位保护战略的peptide.Fmoc-Lys-OHS对生物化学,制药和材料科学的研究至关重要,因为精确的peptide组合至关重要.

结构式图片

相似化合物

139262-23-0 110990-08-4 10009-20-8

欧盟法规

C&L通报

上下游产品

CAS号71989-26-9 Nα-芴甲氧羰基-Nε-叔丁氧... | CAS号86060-82-4 N'-芴甲氧羰基-N-苄氧羰基... | CAS号849752-40-5 methylN2-(((9H-... | CAS号1225187-10-9 (9H-fluoren-9-y... | CAS号1225187-14-3 (9H-fluoren-9-y... | CAS号56-87-1 L-赖氨酸 | CAS号28920-43-6 芴甲氧羰酰氯(Fm°C-Cl) | CAS号201004-23-1 Nα-Fm°C-Nepsilo... | CAS号56-87-1 L-赖氨酸 | CAS号76265-69-5 Fm°C-N'-三氟乙酰基-L-赖氨酸 | CAS号159857-60-0 N-[(9H-芴-9-基甲氧基... | CAS号146982-27-6 芴甲氧羰基-赖氨酸 | CAS号146987-10-2 N-FM°C-N'-生物素-L-赖氨酸 | CAS号159610-89-6 6-叠氮基-N-[(9H-芴-... | CAS号150629-67-7 N-Fm°C-N'-[1-(4... | CAS号204777-78-6 N-芴甲氧羰基-N’-[1-(... | CAS号122903-68-8 芴甲氧羰基-N6-三甲基硅乙氧...

合成工艺路线路线简述

    (S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-6-(((4-甲氧基苯基)二苯基甲基)氨基)己酸置于三氟乙酸体系中,用 二氯甲烷 用作溶剂,化学反应 1.0H,反应生成Fmoc-赖氨酸
    参考文献:微波辅助合成内消旋羧基烷基 Bodipy 及其在荧光成像中的应用
    标题:微波辅助合成内消旋羧基烷基 Bodipy 及其在荧光成像中的应用
    摘要:在该研究中,公开了一种用于合成具有游离羧酸基团(随后与肽偶联)的模块化内消旋-Bodipy(硼二吡咯亚甲基)衍生物的显着改进方法.该方法提供了一种非常有效的合成路线,其总产率比其他报告高出三倍以上.所得内消旋-Bodipy 酸允许进一步容易地掺入肽中.Meso-Bodipy 肽显示出 495-498 Nm 的最大吸收和 504-506 Nm 的发射最大值,33 383-80 434 M-1 Cm-1的摩尔吸收系数和 0.508-0.849 的荧光量子产率.中观评估了-Bodipy-C(Rgdyk) 肽的血浆稳定性,然后评估其在体内和离体的荧光成像适用性(被证明甚至可以持续长达 4 小时) .由于自发荧光,体内光学成像受到限制,然而,离体组织分析显示 Bodipy-C(Rgdyk) 内化和癌症检测,从而使其成为一种新的肿瘤整合素相关荧光探针,同时显示染料没有干扰该配体结合受体的特性.
    Doi:10.1039/d0Ob01415J

    海关参考信息

    专利信息


    专利号:US-2008287649-A1
    优先权日:2006-12-29
    标 题 :Methods for the synthesis of cyclic peptides
    发明人:CHEN LIN; HAN YEUN-KWEI; ROBERTS CHRISTOPHER R
    权利人:CHEN LIN; HAN YEUN-KWEI; ROBERTS CHRISTOPHER R
    摘要:Methods for the synthesis of cyclic peptides are provided, as well as novel dipeptide compounds. The methods include the solid phase synthesis of a dipeptide, which is the coupled to a second peptide in a solid phase reaction. The peptide is then cyclized following the coupling reaction. The methods and dipeptides are particularly useful for the synthesis of MC-4 receptor agonist peptides.

    专利号:WO-9837078-A1
    优先权日:1997-02-20
    标题 :Solid phase and combinatorial synthesis of substituted thiophenes and of arrays of substituted thiophenes
    发明人:DOERWALD FLORENCIO ZARAGOZA
    权利人:NOVO NORDISK AS
    摘要:A solid phase method for the synthesis of a plurality of differently substituted thiophenes with a wide variety of side-chain substituents as compounds of potential therapeutic interest. The thiophenes are prepared by reaction of a substrate-bound primary or secondary amine with a thiophosgene equivalent and reaction of the resulting intermediate with an acceptor-substituted acetonitrile in the presence of a base. Alkylation with an appropriate alkyl halide, followed by Thorpe-Ziegler-cyclization yields differently substituted, support-bound 3-aminothiophenes. These may be screened on the substrate or cleaved from the substrate and then screened in solution. Alternatively, the resin-bound 3-amino thiophenes or the synthetic intermediates can be subjected to further synthetic transformations (N-acylation, reduction) on the support, which permits the preparation of further therapeutically interesting compounds. The efficient synthesis of a wide variety of thiophenes using automated synthesis technology of the present method makes these compounds attractive candidates for the generation and rapid screening of diverse thiophene-based libraries. The method disclosed here provides an easy and fast access to highly diverse heterocyclic compounds of therapeutic interest, amenable to automatization.

    专利号:US-6136984-A
    优先权日:1996-04-22
    标 题 :Solid phase and combinatorial synthesis of substituted thiophenes and of arrays of substituted thiophenes
    发明人:DOERWALD FLORENCIO ZARAGOZA
    权利人:NOVO NORDISK AS
    摘要:A solid phase method for the synthesis of a plurality of differently substituted thiophenes with a wide variety of side-chain substituents as compounds of potential therapeutic interest is disclosed. The thiophenes are prepared by acylation of a substrate-bound primary or secondary amine with cyanoacetic acid and reaction of the resulting cyanoacetamide with an isothiocyanate in the presence of a base. Alkylation with an appropriate alkyl halide, followed by Thorpe-Ziegier-cyclization yields differently substituted, support-bound 3-aminothiophenes. These may be screened on the substrate or cleaved from the substrate and then screened in solution. Alternatively, the resin-bound 3-amino thiophenes or the synthetic intermediates can be subjected to further synthetic transformations (N-acylation, reduction) on the support, which permits the preparation of further therapeutically interesting compounds. The efficient synthesis of a wide variety of thiophenes using automated synthesis technology of the present method makes these compounds attractive candidates for the generation and rapid screening of diverse thiophene-based libraries. The method disclosed here provides an easy and fast access to highly diverse heterocyclic compounds of therapeutic interest, amenable to automatization.

    专利号:US-5847150-A
    优先权日:1996-04-24
    标题 :Solid phase and combinatorial synthesis of substituted 2-methylene-2, 3-dihydrothiazoles and of arrays of substituted 2-methylene-2, 3-dihydrothiazoles
    发明人:DORWALD FLORENCIO ZARAGOZA
    权利人:NOVO NORDISK AS
    摘要:A solid phase method for the synthesis of a plurality of differently substituted 2-methylenethiazoles with a wide variety of side-chain substituents as compounds of potential therapeutic interest. The 2-methylenethiazoles are prepared by acylation of a substrate-bound primary or secondary amine with cyanoacetic acid and reaction of the resulting cyanoacetamide with an isothiocyanate in the presence of a base. Alkylation with an appropriate alkyl halide under acidic conditions yields differently substituted, support-bound 2-methylene-2,3-dihydrothiazoles. These may be screened on the substrate or cleaved from the substrate and then screened in solution. The efficient synthesis of a wide variety of 2-methylenethiazoles using automated synthesis technology of the present method makes these compounds attractive candidates for the generation and rapid screening of diverse thiazole-based libraries. The method disclosed here provides an easy and fast access to highly diverse heterocyclic compounds of therapeutic interest, amenable to automatization.

    专利号:US-11518794-B2
    优先权日:2016-08-19
    标 题:Synthesis method for liraglutide with low racemate impurity
    发明人:FU YUQING; MA HONGJI; LI XINYU; ZHANG LIXIANG; ZHI QIN; WU LIFEN; LIU ZICHENG
    权利人:SHENZHEN JYMED TECH CO LTD
    摘要:A synthesis method for low-racemization impurity liraglutide comprises the following steps: performing synthesis to obtain a propeptide, coupling 2 to 5 peptides comprising Thr-Phe on the propeptide by using a solid-phase synthesis method; further, performing solid-phase synthesis to obtain a liraglutide resin; the liraglutide resin is cracked after modification, or the liraglutide resin is directly cracked, purified and frozen dry, so as to obtain the liraglutide. The provided liraglutide synthesis method effectively restrains or reduces the generation of racemization impurity D-Thr 5 highly similar to a product property, which facilitates the purification of the coarse liraglutide, and the high yield of the liraglutide is ensured, thereby greatly reducing production costs; during the synthesis of the liraglutide, the syntheses between dipeptide fragments, tripeptide fragments, the tetrapeptide fragments and pentapeptide fragments and the Gly-resin or the syntheses between the combination of the dipeptide fragments, the tripeptide fragments, the tetrapeptide fragments and pentapeptide fragments and the Gly resin can be carried out at the same time, and accordingly the synthesis time is shortened to some extent.

    专利号:US-12251674-B2
    优先权日:2012-11-14
    标 题:Substrates, systems, and methods for array synthesis and biomolecular analysis
    发明人:RAJASEKARAN JOHN J; JAYARAMAN VASANTH; WANG TIANHAO; BEI KANG; KRISHNAMURTHY HARI KRISHNAN; VEDANTHAM PUNITHA
    权利人:VIBRANT HOLDINGS LLC
    摘要:Disclosed herein are formulations, substrates, and arrays. In certain embodiments, substrates and arrays comprise a porous layer for synthesis and attachment of polymers or biomolecules. Also disclosed herein are methods for manufacturing and using the formulations, substrates, and arrays, including porous arrays. Also disclosed herein are formulations and methods for one-step coupling, e.g., for synthesis of peptides in an N→C orientation. In some embodiments, disclosed herein are formulations and methods for high efficiency coupling of biomolecules to a substrate.
    湖北恒绿源科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.hbhlykj.com
    企业联系电话:027-88188016👤
    📞湖北恒绿源科技有限公司 ⚠️参考联系方式
    联系人:高婕
    电话:027-88188016
    手机:18062414339
    传真:027-88188026
    邮箱:sales@hbhlykjtech.com
    通信地址: 湖北省武汉市江岸区黄孝河路182号
    邮编: 430012
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:湖北省武汉市江岸区黄孝河路182号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    成都安米诺泰医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.aminotp.com
    电话: 028-85755578 18140172005👤
    📞成都安米诺泰医药科技有限公司 ⚠️参考联系方式

    销售电话:028-85755578 18140172005
    邮箱:sales@aminotp.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海易信生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.bioyeexin.com
    电话: 021-54176788 13671761800👤
    📞上海易信生物科技有限公司 ⚠️参考联系方式

    销售电话:021-54176788 13671761800
    邮箱:sales@bioyeexin.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海市水清路999弄61号602室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    常州欣宜晨药业有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.xycpharm.com
    企业联系电话:0519-85566998👤
    📞常州欣宜晨药业有限公司 ⚠️参考联系方式
    联系人:徐经理
    电话:0519-85566998
    手机:18502571086
    传真:0519-85566998
    邮箱:xycpharm@163.com
    通信地址: 江苏省常州市天宁区劳动东路388号
    邮编:
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省常州市天宁区劳动东路388号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:Solid-Phase Synthesis Of C-Terminal Peptide Aldehydes From Amino Acetals Anchored To A Backbone Amide Linker (Bal) Handle
    作者:Fanny Guillaumie,Joseph C Kappel,Nicholas M Kelly,George Barany,Knud J Jensen |发布日期:2000.8
    摘要:Peptide Aldehydes Were Synthesized, Starting From Amino Acetals, By A Solid-Phase Backbone Amide Linker (Bal) Strategy.

    合成参考文献


    摘要:La Venia, A.; Kovalová, A.; Vrabel, M., Science of Synthesis, (2021) , 103.
    参考文献:10.1021/bc034128s
    摘要:Stephenson KA, Zubieta J, Banerjee SR, Levadala MK, Taggart L, Ryan L, McFarlane N, Boreham DR, Maresca KP, Babich JW, Valliant JF. A New Strategy for the Preparation of Peptide-Targeted Radiopharmaceuticals Based on an Fmoc-Lysine-Derived Single Amino Acid Chelate (SAAC). Automated Solid-Phase Synthesis, NMR Characterization, and in Vitro Screening of fMLF(SAAC)G and fMLF[(SAAC−Re(CO)3)+]G. Bioconjugate Chem. 2003 Nov 22;15(1):128–36. doi: 10.1021/bc034128s.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知